EMA PUSHES AHEAD WITH ANTI-FRAUD STRATEGY IN 2016
January 1st, 2016
THE EUROPEAN Medicines Agency’s (EMA) new anti-fraud office is to undertake regular surveys of the European Union (EU) regulator’s staff to ensure they are proficient on anti-fraud and ethics knowledge. The goal is to root out the potential for collusion and corruption – and further anti-fraud training will be organised, depending on the results. The office is also planning to assess if its selection and procurement procedures demonstrate sufficient fraud resistance and address any gaps identified. Meanwhile, this summer, the office is to develop internal ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.